iBio Inc (IBIO)
2.01
+0.16
(+8.65%)
USD |
NYAM |
May 02, 16:00
2.01
0.00 (0.00%)
After-Hours: 16:00
iBio 1 Year Total Returns (Daily): -91.51% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -91.51% |
April 30, 2024 | -92.08% |
April 29, 2024 | -92.31% |
April 26, 2024 | -91.93% |
April 25, 2024 | -92.77% |
April 24, 2024 | -91.95% |
April 23, 2024 | -92.69% |
April 22, 2024 | -93.15% |
April 19, 2024 | -93.38% |
April 18, 2024 | -91.81% |
April 17, 2024 | -90.74% |
April 16, 2024 | -90.80% |
April 15, 2024 | -90.90% |
April 12, 2024 | -90.38% |
April 11, 2024 | -91.27% |
April 10, 2024 | -91.22% |
April 09, 2024 | -91.18% |
April 08, 2024 | -90.81% |
April 05, 2024 | -91.35% |
April 04, 2024 | -91.64% |
April 03, 2024 | -91.35% |
April 02, 2024 | -93.12% |
April 01, 2024 | -91.95% |
March 28, 2024 | -91.29% |
March 27, 2024 | -93.09% |
Date | Value |
---|---|
March 26, 2024 | -97.26% |
March 25, 2024 | -97.39% |
March 22, 2024 | -97.34% |
March 21, 2024 | -97.80% |
March 20, 2024 | -97.71% |
March 19, 2024 | -97.27% |
March 18, 2024 | -97.29% |
March 15, 2024 | -97.15% |
March 14, 2024 | -96.71% |
March 13, 2024 | -96.86% |
March 12, 2024 | -96.91% |
March 11, 2024 | -96.86% |
March 08, 2024 | -96.99% |
March 07, 2024 | -97.08% |
March 06, 2024 | -96.36% |
March 05, 2024 | -96.21% |
March 04, 2024 | -96.12% |
March 01, 2024 | -95.60% |
February 29, 2024 | -95.08% |
February 28, 2024 | -95.27% |
February 27, 2024 | -95.32% |
February 26, 2024 | -95.04% |
February 23, 2024 | -94.74% |
February 22, 2024 | -96.00% |
February 21, 2024 | -96.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-97.80%
Minimum
Mar 21 2024
1.36K%
Maximum
Nov 19 2020
18.76%
Average
-67.35%
Median
Jan 18 2022
1 Year Total Returns (Daily) Benchmarks
Lixte Biotechnology Holdings Inc | -48.93% |
PAVmed Inc | -65.96% |
Avalo Therapeutics Inc | -97.84% |
Imunon Inc | 0.77% |
Ocugen Inc | 97.57% |